| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000046893 |
| Receipt No. | R000053504 |
| Scientific Title | Clinical effects of extension of meal intake time in patients with type 2 diabetes: a prospective observational study |
| Date of disclosure of the study information | 2022/02/13 |
| Last modified on | 2022/02/13 (Ver. 1) |
| Basic information | ||
| Public title | Clinical effects of meal intake time intervention in patients with type 2 diabetes: a prospective observational study | |
| Acronym | Meal intake time intervention study | |
| Scientific Title | Clinical effects of extension of meal intake time in patients with type 2 diabetes: a prospective observational study | |
| Scientific Title:Acronym | Meal intake time intervention study | |
| Region |
|
|
| Condition | ||
| Condition | type 2 diabetes | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to investigate the clinical effect of extension of meal intake time in patients with type 2 diabetes. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Comparing the difference in HbA1c between normal nutritional guidance and same nutritional guidance plus extension of meal intake time for dinner. |
| Key secondary outcomes | 1: Comparing the difference in body weight and/or BMI between normal nutritional guidance and same nutritional guidance plus extension of meal intake time for dinner.
2: Comparing the difference in several factors as follow between normal nutritional guidance and same nutritional guidance plus extension of meal intake time for dinner. 1.GA 2.FPG (mg/dL) 3.systolic blood pressure (mmHg) 4.diastolic blood pressure (mmHg) 5.lipid profile 6.renal function: eGFR (ml/min/1.73m2) 7.liver function: AST, ALT, GGT 8.FIB-4 index 3: Association the change of HbA1c and several factors as follow between two groups. 1.GA 2.FPG (mg/dL) 3.systolic blood pressure (mmHg) 4.diastolic blood pressure (mmHg) 5.lipid profile 6.renal function: eGFR (ml/min/1.73m2) 7.liver function: AST, ALT, GGT 8.FIB-4 index 9.body weight (kg), BMI (kg/mm2) 10.detail of medication and number of take medicine 4: Association the change of body weight and several factors as follow between two groups. 1.GA 2.FPG (mg/dL) 3.systolic blood pressure (mmHg) 4.diastolic blood pressure (mmHg) 5.lipid profile 6.renal function: eGFR (ml/min/1.73m2) 7.liver function: AST, ALT, GGT 8.FIB-4 index 9.HbA1c (%) 10.detail of medication and number of take medicine |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Placebo |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Provide normal nutritional guidance plus instruct to double their meal intake time for dinner. | |
| Interventions/Control_2 | Provide normal nutritional guidance. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The selection criteria for the subjects are as follow.
1. Patients who have been diagnosed as type 2 diabetes. 2. Over 20 years old. |
|||
| Key exclusion criteria | The exclusion criteria for the subjects are as follow.
1. Subjects with acute and/or chronic inflammation 2. Subjects with fresh cardiovascular and/or cerebrovascular diseases 3. Subjects with liver cirrhosis. 4. Subjects with severe respiratory disease or severe heart failure 5. Subjects with alcoholicsm or medicinal intoxication 6. Subjects with psychosis 7. Subjects who doctors judge as unfitness |
|||
| Target sample size | 80 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nishinihon Hospital | ||||||
| Division name | Metabolic Medicine | ||||||
| Zip code | 861-8034 | ||||||
| Address | 3-20-1 Hattanda, Higashi-ku, Kumamoto | ||||||
| TEL | 096-380-1111 | ||||||
| takeshim@gpo.kumamoto-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nishinihon Hospital | ||||||
| Division name | Department of Nutrition | ||||||
| Zip code | 861-8034 | ||||||
| Address | 3-20-1 Hattanda, Higashi-ku, Kumamoto | ||||||
| TEL | 0963801111 | ||||||
| Homepage URL | |||||||
| hcaelb_a@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | Department of Metabolic Medicine, Nishinihon Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding
Department of Metabolic Medicine, Nishinihon Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Nishinihon Hospital Ethics Review Committee |
| Address | 3-20-1 Hattanda, Higashi-ku, Kumamoto |
| Tel | 0963801111 |
| takeshim@gpo.kumamoto-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 西日本病院(熊本) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053504 |